With regard to the prevalence of IgA-tTG antibodies in psoriasis, we have identified five cross-sectional cohort studies [63,68,80,82,83] and ten case–control studies [65,69,71,75,76,84,85,86,87,88] (previously mentioned in Table 2). Here, CD79A is linked to psoriasis.